Global Market Access

Paying for Performance: EFPIA’s Catch-22 for European Drug Pricing

A leaked internal paper could signal a tidal shift in European drug pricing as companies and payers continue their combined march toward value-based pricing. However, the concession by industry could come at a price to payers, namely their reliance on cost containment measures such as external reference pricing, which suggests that this roadmap is just […]

Russia: Capricious or Compulsory Licensing?

Though compulsory licensing of pharmaceuticals in the BRICS (Brazil, Russia, India, China, and South Africa) is quite commonplace, Russia has historically bucked that trend. However, facing some diseases in epidemic proportions and with the high cost of therapies – especially those for HIV/AIDS and Hepatitis C – 2016 may be a turning point in Russian […]

Oil and Healthcare: Oil Prices Create Havoc in the Land of Soccer and Samba

Until recently, Brazil – like many other oil producing countries – benefited from high oil prices, experiencing years of economic growth and prosperity. However, in the two years since oil prices began falling in 2014, much has changed. 2016 should be a year of celebration in Brazil, which will be hosting the 31st Summer Olympics; […]

Latin America scrambles to contain Zika virus

From relative obscurity, the Zika virus burst into global consciousness in early 2016 as the arbovirus spread rapidly across the Latin American region and threatens to hit the United States. In its wake, the Zika virus is leaving countries scrambling to stop it before more people become infected, with particular focus on pregnant women. Although […]